Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer
Background To evaluate outcomes of laparoscopic retroperitoneal para-aortic lymphadenectomy for stage 1b3-3b cervical cancer.Methods Pathology databases searched for all para-aortic lymphadenectomy cases 2005–2016. Descriptive statistics were used to analyse baseline characteristics, cox models for...
Saved in:
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Journal of Obstetrics and Gynaecology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/01443615.2024.2344529 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1841553129035792384 |
---|---|
author | Claire Newton Radha Graham Viola Liberale Matthew Burnell Usha Menon Tim Mould Adeola Olaitan Nicola Macdonald Martin Widschwendter Kostas Doufekas Mary McCormack Anita Mitra Rupali Arora Ranjit Manchanda |
author_facet | Claire Newton Radha Graham Viola Liberale Matthew Burnell Usha Menon Tim Mould Adeola Olaitan Nicola Macdonald Martin Widschwendter Kostas Doufekas Mary McCormack Anita Mitra Rupali Arora Ranjit Manchanda |
author_sort | Claire Newton |
collection | DOAJ |
description | Background To evaluate outcomes of laparoscopic retroperitoneal para-aortic lymphadenectomy for stage 1b3-3b cervical cancer.Methods Pathology databases searched for all para-aortic lymphadenectomy cases 2005–2016. Descriptive statistics were used to analyse baseline characteristics, cox models for treatment affect after accounting for variables, and Kaplan Meier curves for survival (STATA v15).Results 191 patients had 1b3-3b cervical cancer of which 110 patients had Para-aortic lymphadenectomy. 8 (7.3%) patients stage 1b3, 82 (74.6%) stage 2b, and 20 (18.1%) stage 3b cervical cancer. Mean lymph node count 11.7 (SD7.6). The intra-operative and post-operative 30 day complication rates were 8.8% (CI: 4.3%, 15.7%) and 5.3% (CI: 1.9%, 11.2%) respectively.Para-aortic nodes were apparently positive on CT/MRI in 5/110 (5%) cases. Cancer was found in 10 (8.9%, CI: 4.3%, 15.7%) cases on histology, all received extended field radiotherapy. Only 2 were identified on pre-operative CT/MRI imaging. 3 of 10 suspected node-positive cases on CT/MRI had negative histology. Para-aortic lymphadenectomy led to alteration in staging and radiotherapy management in 8 (8%, CI: 3.7%, 14.6%) patients. Mean overall survival 42.81 months (SD = 31.79 months). Survival was significantly higher for women undergoing PAN (50.57 (SD 30.7) months) compared to those who didn’t (31.27 (SD 32.5) months)Conclusion Laparoscopic retroperitoneal para-aortic lymphadenectomy is an acceptable procedure which can guide treatment in women with locally advanced cervical cancer. |
format | Article |
id | doaj-art-13aad1304a9a495b96a43affc1b98ef8 |
institution | Kabale University |
issn | 0144-3615 1364-6893 |
language | English |
publishDate | 2024-12-01 |
publisher | Taylor & Francis Group |
record_format | Article |
series | Journal of Obstetrics and Gynaecology |
spelling | doaj-art-13aad1304a9a495b96a43affc1b98ef82025-01-09T12:13:17ZengTaylor & Francis GroupJournal of Obstetrics and Gynaecology0144-36151364-68932024-12-0144110.1080/01443615.2024.2344529Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancerClaire Newton0Radha Graham1Viola Liberale2Matthew Burnell3Usha Menon4Tim Mould5Adeola Olaitan6Nicola Macdonald7Martin Widschwendter8Kostas Doufekas9Mary McCormack10Anita Mitra11Rupali Arora12Ranjit Manchanda13Gynaecology Oncology, University Hospitals Bristol NHS Foundation trust, Bristol, UKUniversity College London Hospital NHS Foundation Trust, London, UKUniversity College London Hospital NHS Foundation Trust, London, UKMRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UKMRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UKUniversity College London Hospital NHS Foundation Trust, London, UKUniversity College London Hospital NHS Foundation Trust, London, UKUniversity College London Hospital NHS Foundation Trust, London, UKUniversity College London Hospital NHS Foundation Trust, London, UKUniversity College London Hospital NHS Foundation Trust, London, UKUniversity College London Hospital NHS Foundation Trust, London, UKUniversity College London Hospital NHS Foundation Trust, London, UKUniversity College London Hospital NHS Foundation Trust, London, UKMRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UKBackground To evaluate outcomes of laparoscopic retroperitoneal para-aortic lymphadenectomy for stage 1b3-3b cervical cancer.Methods Pathology databases searched for all para-aortic lymphadenectomy cases 2005–2016. Descriptive statistics were used to analyse baseline characteristics, cox models for treatment affect after accounting for variables, and Kaplan Meier curves for survival (STATA v15).Results 191 patients had 1b3-3b cervical cancer of which 110 patients had Para-aortic lymphadenectomy. 8 (7.3%) patients stage 1b3, 82 (74.6%) stage 2b, and 20 (18.1%) stage 3b cervical cancer. Mean lymph node count 11.7 (SD7.6). The intra-operative and post-operative 30 day complication rates were 8.8% (CI: 4.3%, 15.7%) and 5.3% (CI: 1.9%, 11.2%) respectively.Para-aortic nodes were apparently positive on CT/MRI in 5/110 (5%) cases. Cancer was found in 10 (8.9%, CI: 4.3%, 15.7%) cases on histology, all received extended field radiotherapy. Only 2 were identified on pre-operative CT/MRI imaging. 3 of 10 suspected node-positive cases on CT/MRI had negative histology. Para-aortic lymphadenectomy led to alteration in staging and radiotherapy management in 8 (8%, CI: 3.7%, 14.6%) patients. Mean overall survival 42.81 months (SD = 31.79 months). Survival was significantly higher for women undergoing PAN (50.57 (SD 30.7) months) compared to those who didn’t (31.27 (SD 32.5) months)Conclusion Laparoscopic retroperitoneal para-aortic lymphadenectomy is an acceptable procedure which can guide treatment in women with locally advanced cervical cancer.https://www.tandfonline.com/doi/10.1080/01443615.2024.2344529Cervical cancerlymphadenectomy |
spellingShingle | Claire Newton Radha Graham Viola Liberale Matthew Burnell Usha Menon Tim Mould Adeola Olaitan Nicola Macdonald Martin Widschwendter Kostas Doufekas Mary McCormack Anita Mitra Rupali Arora Ranjit Manchanda Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer Journal of Obstetrics and Gynaecology Cervical cancer lymphadenectomy |
title | Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer |
title_full | Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer |
title_fullStr | Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer |
title_full_unstemmed | Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer |
title_short | Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer |
title_sort | outcomes of minimal access retroperitoneal para aortic lymphadenectomy in patients with locally advanced cervical cancer |
topic | Cervical cancer lymphadenectomy |
url | https://www.tandfonline.com/doi/10.1080/01443615.2024.2344529 |
work_keys_str_mv | AT clairenewton outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer AT radhagraham outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer AT violaliberale outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer AT matthewburnell outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer AT ushamenon outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer AT timmould outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer AT adeolaolaitan outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer AT nicolamacdonald outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer AT martinwidschwendter outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer AT kostasdoufekas outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer AT marymccormack outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer AT anitamitra outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer AT rupaliarora outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer AT ranjitmanchanda outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer |